Michael Halaiko and Alex Moylan, shareholders in the law firm of Baker Donelson, discuss the Trump Administration’s recent executive orders on domestic production of critical medicines.
The April trade report showed imports of consumer goods slumped $33 billion, largely due to a sharp decline in inbound shipments of pharmaceutical preparations.
By 2030, we will see a growing divide between companies that embraced emissions reduction as a competitive advantage and those that stalled due to short-term uncertainty.
Large language models are enhancing decision-making, automating routine tasks and improving efficiency across procurement, logistics, inventory management and supplier collaboration.
Immigration and Customs Enforcement has arrested tens of thousands of people living in the U.S. without legal status since January, when Trump took office.
The agreement includes provisions for the rapid sharing of data about new diseases, to ensure scientists and pharmaceutical companies can work more quickly to develop treatments and vaccines
Most companies said bringing back supply chains within the U.S. could as much as double their costs, and it would be more cost-effective to relocate them to lower-tariffed countries.
Even balanced against elevated levels earlier this year, total 2025 cargo volume could show a net decline of 15% or more unless the situation with tariffs changes.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.